NON-INVASIVE CANCER SOLUTIONS
Safe | Accurate | Easy on the Patient
WORLDWIDE
Abstract A49: Viable Circulating Ensembles of Tumor-Associated Cells Persist in Pretreated Patients with Solid Organ Cancers showing no Radiologically Detectable Disease
DOI: 10.1158/1557-3265.LiqBiop20-A49 Published June 2020
Abstract B16: Non-Invasive Liquid Biopsies for Guideline-Compliant Diagnostic Assessment in Ovarian Cancers
DOI: 10.1158/1557-3265.LiqBiop20-B16 Published June 2020
Abstract B61: Encyclopedic Non-Invasive Liquid Biopsies for Differential Diagnosis in Prostate Cancer
DOI: 10.1158/1557-3265.LiqBiop20-B61 Published June 2020
Abstract B62: Wholesome Non-Invasive Liquid Biopsies for Pharmacodiagnostic Work-Up in Breast Cancer
DOI: 10.1158/1557-3265.LiqBiop20-B62 Published June 2020
Abstract B15: Circulating Tumor Cells Express Tissue Specific Antigens in Multiple Cancers
DOI: 10.1158/1557-3265.LiqBiop20-B15 Published June 2020
Abstract B17: An mRNA Signature that Accurately Discerns Gliomas from Healthy Individuals
DOI: 10.1158/1557-3265.LiqBiop20-B17 Published June 2020
Multi-Analyte Interrogation Based Treatment of Advanced Refractory Cancers
DOI: 10.1200/JCO.2020.38.15_suppl.e15624 Journal of Clinical Oncology 38, no. 15_suppl. Published online May 25, 2020.
Circulating Microtumors: A functional Hallmark for Cancer Detection and Management
DOI: 10.1200/JCO.2020.38.15_suppl.3544 Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020) 3544-3544. Published online May 25, 2020.
Multi-Analyte Liquid Biopsies Based Treatment in Advanced Refractory Cancers
DOI: 10.1200/JCO.2020.38.15_suppl.e15623 Journal of Clinical Oncology 38, no. 15_suppl. Published online May 25, 2020.
Liquid Biopsies to Enable Non-Invasive Real-Time Functional Chemoresistance Profiling in Solid Organ Cancers
DOI: 10.1200/JCO.2020.38.15_suppl.3525 Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020) 3525-3525. Published online May 25, 2020.
Encyclopedic Tumor Analysis Guided Treatments with Conventional Drugs Outperform Available Alternatives in Refractory Head and Neck Cancers
April 1, 2020, Volume 106, Issue 5, Pages 1133–1134
Viable Circulating Ensembles of Tumor Associated Cells Persist in Patients with No Radiologically Detectable Disease After Treatment in Head and Neck Cancer
April 1, 2020, Volume 106, Issue 5, Page 1133
Circulating Tumor Associated Cells in Head and Neck Cancers are Resistance Educated per Previous Chemotherapy Treatments
Volume 106, Issue 5, P1121, April 01, 2020
Clinical Utility of Encyclopedic Tumor Analysis to Treat Breast Cancer Patients who have Failed Standard of Care Treatments
Volume/Issue: Volume 18: Issue 3.5; Online Publication Date: 20 Mar 2020
Circulating Ensembles of Tumor-Associated Cells in Genitourinary Cancers
DOI: 10.1200/JCO.2020.38.6_suppl.718 Journal of Clinical Oncology 38, no. 6_suppl (February 20, 2020) 718-718
Abstract P4-01-17: Viable Circulating Ensembles of Tumor Associated Cells Persist in Patients with No Radiologically Detectable Disease after Treatment in Breast Cancer
DOI: 10.1158/1538-7445.SABCS19-P4-01-17 Published February 2020
Abstract P4-01-17: Viable Circulating Ensembles of Tumor Associated Cells Persist in Patients with No Radiologically Detectable Disease After Treatment in Breast Cancer
DOI: 10.1158/1538-7445.SABCS19-P4-01-17 Published February 2020
Abstract P6-10-11: In Vitro Chemo Interrogation of Viable Circulating Tumor Associated Cells from Breast Cancer Patients
DOI: 10.1158/1538-7445.SABCS19-P6-10-11 Published February 2020
Abstract P4-01-05: Circulating Ensembles of Tumor Associated Cells for Detection of Breast Cancer
DOI: 10.1158/1538-7445.SABCS19-P4-01-05 Published February 2020
Encyclopedic Tumor Analysis Offers Viable Efficacious Treatment Options in Advanced Refractory Head and Neck Cancers
In Press
Non-invasive Real-time Chemoresistance Profiling of Circulating Tumor Associated Cells in Head and Neck Cancers
In Press
PD-L1 Profiling of Circulating Tumor Cells for Immune Checkpoint Inhibitor Therapy in Head and Neck Cancers
Journal of Clinical Oncology 38, no. 5_suppl (February 10, 2020) 36-36
PD-L1 Profiling of Circulating Tumor Cells for Immune Checkpoint Inhibitor Therapy in Gastroesophageal Cancers
Journal of Clinical Oncology 38, no. 5_suppl (February 10, 2020) 29-29
Effect of Previous Chemotherapy Treatments on Circulating Tumor-Associated Cells in Colorectal Cancer
Journal of Clinical Oncology 38, no. 4_suppl (February 01, 2020) 194-194
Encyclopedic Liquid Biopsies for Guideline-Compliant Diagnostic Work-up in Gastrointestinal Cancers
Journal of Clinical Oncology 38, no. 4_suppl (February 01, 2020) 799-799
Circulating Ensembles of Tumor-Associated Cells in Gastrointestinal Cancers
Journal of Clinical Oncology 38, no. 4_suppl (February 01, 2020) 808-808
Circulating Ensembles of Tumor-Associated Cells Are Ubiquitous in Lung Cancers
Journal of Thoracic Oncology. February 2020; Volume 15, Issue 2, Supplement, Page S16
Circulating Tumor-Associated Cells in Lung Cancers Are Resistance-Educated per Previous Chemotherapy Treatments
Journal of Thoracic Oncology. February 2020; Volume 15, Issue 2, Supplement, Page S37
Encyclopedic Tumor Analysis Guided Treatments with Conventional Drugs Outperform Available Alternatives in Refractory Cancers
Annals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-098
mTOR Inhibitors in Combination Regimens Guided by Encyclopedic Tumour Analysis Show Superior Outcomes Compared to Monotherapy in Refractory Cancers
Annals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-115
Encyclopedic Tumour Analysis (ETA) Guided Combination Regimens of Hormone Receptor Antagonists with Other Systemic Agents for Treatment of Refractory Cancers
Annals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-106
Circulating Tumour Associated Cells in Esophageal Cancers are Resistance Educated Per Previous Chemo Treatments
Annals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-050
Artificial Intelligence can Detect Lung Cancer from High Resolution Microscopic Images of Conditioned Peripheral Blood
Journal of Thoracic Oncology. 2019 Nov 1;14(11):S1138
Diagnostic Non-Invasive Biopsy can Substitute Conventional Tissue Dependent Procedures in Suspected Cases of Lung Cancer
Journal of Thoracic Oncology. 2019 Nov 1;14(11):S1137-8
Clinical Utility of Encyclopedic Tumour Analysis to Treat Patients with Advanced Refractory Head and Neck Cancers
Annals of Oncology, Volume 30, Issue Supplement_9, November 2019, mdz431.008
Clinical Utility of Encyclopedic Tumor Analysis to Treat Patients with Brain Metastasis in Refractory Cancers
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi59–vi60
In Vitro Chemo Resistance Profiles of Circulating Glial Cells Replicate Chemo Characteristics of Tumor Tissue
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi135
Diagnosis of Gliomas Using Circulating Glial Cells
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi153
Prospective, Blinded Plasma Based Analysis for Diagnosis of Newly Diagnosed Glioma
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi157–vi158
Circulating Ensembles of Tumor Associated Cells are Ubiquitous in Breast, Ovarian and Cervical Cancers and Atypical in Asymptomatic Individuals
Year: 2019
Diagnostic Non-Invasive Biopsy can Substitute Conventional Tissue Dependent Procedures in Suspected Cases of Renal Cell Carcinoma
Volume 18, Issue 11, November 2019, Page e3515
Encyclopedic Tumor Analysis Guided Personalized Treatments in Advanced Refractory Malignancies : A Paradigm Shift in Cancer Management
In Press
Encyclopedic Tumor Analysis Guided Personalized Treatments : A Paradigm Shift in Clinical Management of Advanced Refractory Cancers
In Press
Clinical Efficacy of Combination Therapies with Androgen Receptor Antagonists for Treatment of Multiple Refractory Cancers
DOI: 10.1200/JGO.2019.5.suppl.115 Journal of Global Oncology 5, no. suppl (October 07, 2019) 115-115
Tumor Infiltrating Lymphocytes Show in Vitro Cytotoxic Activity Against Tumor Cells in Multiple Cancers
DOI: 10.1200/JGO.2019.5.suppl.111 Journal of Global Oncology 5, no. suppl (October 07, 2019) 111-111
In Vitro Functional Interrogation of Viable Circulating Tumor Associated Cells (C-TACs) for Evaluating Platin Resistance
Annals of Oncology. 2019 Oct 1;30(Supplement_5):mdz268-099
Circulating Ensembles of Tumor Associated Cells are a Hallmark of Breast Cancer and Rare in Healthy Individuals
In Press
Circulating Ensembles of Tumor Associated Cells are a Hallmark of Lung Cancer and Rare in Healthy Individuals
In Press
Circulating Ensembles of Tumor Associated Cells are a Reliable Biomarker of Pancreatic Cancer
In Press
Circulating Tumor Associated Cells in Breast Cancers are Resistance Educated towards Prior Anthracycline Treatments
In Press
Real-time Non-Invasive Chemoresistance Profiling of Circulating Tumor Associated Cells in Breast Cancers to Determine Resistance towards Mitotic Inhibitors
In Press
CONTACT US